St. Francis Health Center, originally St. Francis Hospital was a hospital located in Colorado Springs, Colorado which closed in 2010. The closing came after the opening of St. Francis Medical Center in 2008.

During the past decade, Penrose-Saint Francis Healthcare conducted 178 clinical trials. In the 10-year time frame, 178 clinical trials started and 137 clinical trials were completed, i.e. on average, 77% percent of trials that started reached the finish line to date. In the past 5 years, 66 clinical trials started and 83 clinical trials were completed. i.e. 125.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Penrose-Saint Francis Healthcare" #1 sponsor was "National Cancer Institute (NCI)" with 160 trials, followed by "SWOG Cancer Research Network" with 36 trials sponsored, "Alliance for Clinical Trials in Oncology" with 29 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 21 trials sponsored and "NRG Oncology" with 21 trials sponsored. Other sponsors include 38 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Penrose-Saint Francis Healthcare" #1 collaborator was "National Cancer Institute (NCI)" with 128 trials as a collaborator, "NRG Oncology" with 43 trials as a collaborator, "Canadian Cancer Trials Group" with 10 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator and "SWOG Cancer Research Network" with 7 trials as a collaborator. Other collaborators include 53 different institutions and companies that were collaborators in the rest 43 trials.

According to Clinical.Site data, the most researched conditions in "Penrose-Saint Francis Healthcare" are "Recurrent Breast Carcinoma" (12 trials), "Recurrent Ovarian Carcinoma" (11 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Invasive Breast Carcinoma" (9 trials) and "Breast Cancer" (8 trials). Many other conditions were trialed in "Penrose-Saint Francis Healthcare" in a lesser frequency.

Most popular intervention types in "Penrose-Saint Francis Healthcare" are "Drug" (242 trials), "Other" (173 trials), "Biological" (132 trials), "Procedure" (71 trials) and "Radiation" (59 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (97 trials), "Quality-of-Life Assessment" (72 trials), "Paclitaxel" (44 trials), "Questionnaire Administration" (42 trials) and "Carboplatin" (39 trials). Other intervention names were less common.

The vast majority of trials in "Penrose-Saint Francis Healthcare" are 236 trials for "All" genders, 57 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "Penrose-Saint Francis Healthcare". undefined are not yet recruiting, 69 are recruiting, 132 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 79 completed trials in Penrose-Saint Francis Healthcare, 4 suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Penrose-Saint Francis Healthcare, 7 "Phase 1" clinical trials were conducted, 147 "Phase 2" clinical trials and 157 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 10 trials that are defined as “Not Applicable".

Penrose-Saint Francis Healthcare has several departments that took part in Clinical trials: "Penrose Cancer Center at Penrose Hospital" - 118 trials, "Penrose Hospital - Emergency Medicine" - 3 trials